Clinical Trials in Jerez de la Frontera, Cádiz
20 recruiting
Showing 1–20 of 20 trials
Recruiting
Phase 2
Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
Limited Stage Small Cell Lung CancerThoracic NeoplasmsRespiratory Tract Neoplasms+1 more
Fundación GECP37 enrolled20 locationsNCT07242547
Recruiting
Phase 3
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.
Carcinoma, Non-Small Cell LungResectable Lung Non-Small Cell CarcinomaLung Diseases
Fundación GECP129 enrolled30 locationsNCT06431633
Recruiting
Phase 2
Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia
Myelofibrosis (MF)
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas30 enrolled13 locationsNCT07394153
Recruiting
Phase 3
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps
Sanofi210 enrolled121 locationsNCT06834347
Recruiting
Phase 3
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Colorectal NeoplasmsNeoplasms by SiteGastrointestinal Neoplasms+7 more
Pfizer800 enrolled156 locationsNCT07222800
Recruiting
Phase 3
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Lung CancerNon-small Cell Lung CancerCarcinoma, Non-Small Cell Lung+3 more
Pfizer1,410 enrolled229 locationsNCT07222566
Recruiting
Phase 3
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Non-small Cell Lung CancerCarcinoma, Non-Small Cell LungCarcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer714 enrolled329 locationsNCT06758401
Recruiting
Phase 3
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
AsthmaWheezing
Sanofi90 enrolled74 locationsNCT06191315
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Phase 2
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Chronic Obstructive Pulmonary Disease
Upstream Bio Inc.666 enrolled325 locationsNCT06981078
Recruiting
Phase 2
PALACE: Cemiplimab Trial According to ctDNA Levels
Non-small Cell Lung Cancer MetastaticThoracic NeoplasmsStage IV Non-Small Cell Lung Cancer+3 more
Fundación GECP63 enrolled20 locationsNCT06917573
Recruiting
Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
Cancer
Bayer402 enrolled383 locationsNCT04464226
Recruiting
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Venous Thromboembolism
Manuel Monreal120,000 enrolled257 locationsNCT02832245
Recruiting
Not Applicable
Randomized Double-Blind Trial on Safety and Efficacy of Nanordica Advanced Antibacterial Wound Dressing for Diabetic Foot Ulcer
Diabetic Foot UlcerDiabetic Foot Infection
Nanordica Medical OU170 enrolled11 locationsNCT06667752
Recruiting
Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
CancerThromboembolism
Fundación Sociedad Española de Oncologia Médica700 enrolled48 locationsNCT03855592
Recruiting
Phase 3
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.150 enrolled32 locationsNCT04435990
Recruiting
Phase 2
DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors
NSCLCPancoast Tumor
Fundación GECP22 enrolled29 locationsNCT05684276
Recruiting
RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
Primary Immune Thrombocytopenia (ITP)ITP - Immune Thrombocytopenia
Fundación Española de Hematología y Hemoterapía1,000 enrolled36 locationsNCT06919341
Recruiting
Phase 3
Efficacy and Safety of Antimicrobial Durations Treatment of Infections Associated With Osteosynthesis Material
Infections
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla364 enrolled29 locationsNCT05294796
Recruiting
Phase 2
Study of Elranatamab for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes
Multiple Myeloma in Relapse
PETHEMA Foundation50 enrolled15 locationsNCT06282978